Estimations des analystes de Wall Street pour BioLineRx Ltd. (BLRX): objectif de cours de consensus, recommandations achat/conserver/vente et prévisions de revenus, BPA et EBITDA pour les prochains exercices.
Consensus des analystes
| Achat fort | 0 |
| Achat | 7 |
| Conserver | 0 |
| Vente | 0 |
| Vente forte | 0 |
| Analystes au total | 7 |
| Note moyenne (1-5) | 1.00 |
Surprises de Résultats Récentes
| Date | BPA Réel | BPA Estimé | vs Est. |
|---|---|---|---|
| 2026-11-23 | $-0.39 | ||
| 2026-08-31 | $-0.77 | $-0.15 | -413.3% |
| 2026-05-27 | $-0.58 | $-1.04 | +44.2% |
| 2026-03-23 | $-0.34 | $-0.50 | +32.0% |
| 2025-11-24 | $-0.22 | $-0.41 | +46.3% |
| 2025-08-14 | $-1.00 | $-0.35 | -185.7% |
| 2025-05-27 | $1.39 | $-0.84 | +265.5% |
| 2025-03-31 | $-1.60 | $-0.81 | -98.2% |
Ratios de valorisation
| Prix / Valeur comptable | 0.83 |
| EV / EBITDA | -1.28 |
| Rendement du dividende | 0.00% |
Compte de Résultat (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenus | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $4.8M | $28.9M | $1.2M |
| Coût des Ventes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $3.7M | $9.3M | $758973 |
| Marge Brute | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $1.1M | $19.7M | $430387 |
| R&D | $11.2M | $19.5M | $19.8M | $23.4M | $18.2M | $19.5M | $17.6M | $12.5M | $9.1M | $7.7M |
| Frais Généraux | $5.3M | $5.7M | $5.8M | $4.6M | $4.7M | $5.3M | $11.5M | $31.2M | $28.5M | $3.1M |
| Charges Opérationnelles | $16.5M | $25.2M | $25.6M | $28.1M | $22.9M | $24.8M | $29.2M | $50.8M | $40.1M | $10.8M |
| Résultat Opérationnel | -$16.5M | -$25.2M | -$25.6M | -$28.1M | -$22.9M | -$24.8M | -$29.2M | -$49.7M | -$20.4M | -$10.4M |
| EBITDA | -$15.3M | -$24.8M | -$22.0M | -$22.7M | -$27.6M | -$25.4M | -$22.1M | -$57.1M | $3.9M | -$224770 |
| Charges d'Intérêt | $14000 | $21000 | $21000 | $1.8M | $1.5M | $984000 | $2.2M | $2.2M | $9.2M | $1.3M |
| Résultat Avant Impôts | -$15.8M | -$24.4M | -$23.0M | -$25.4M | -$30.0M | -$27.1M | -$25.0M | -$60.6M | -$9.2M | -$2.0M |
| Impôts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Résultat Net | -$15.8M | -$24.4M | -$23.0M | -$25.4M | -$30.0M | -$27.1M | -$25.0M | -$60.6M | -$9.2M | -$1.2M |
| BPA | $-168.00 | $-162.00 | $-126.00 | $-108.00 | $-72.00 | $-24.48 | $-19.32 | $-37.74 | $-4.62 | $-0.29 |
| BPA Dilué | $-168.00 | $-162.00 | $-126.00 | $-108.00 | $-72.00 | $-24.48 | $-19.32 | $-37.74 | $-4.62 | $-0.29 |
| Actions en Circulation (Diluées) | $93574 | $149951 | $180992 | $244011 | $421407 | $1.1M | $1.3M | $1.6M | $2.0M | $4.1M |
Prix
| Prix | $2.52 |
| Capitalisation | $11M |
| Bourse | NASDAQ |
| Pays | IL |
Entreprises liées: ADAP · ADTX · AIMD · ANL · APLM · GOVX · ICU
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de BLRX: Vue d'ensemble · Financiers · Valorisation · Statistiques · Technique · Actionnariat · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions